These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19802989)

  • 1. The microbiological assay of ceftazidime.
    Thornton JE
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():225-6. PubMed ID: 19802989
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftazidime regression studies.
    Crosse R; Burt DG; Gardner MJ
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():221-3. PubMed ID: 19802988
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftazidime susceptibility testing--disc loading.
    Crosse R; Burt DG; Gardner MJ
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():217-9. PubMed ID: 19802987
    [No Abstract]   [Full Text] [Related]  

  • 4. Behaviour of ceftazidime towards beta-lactamases.
    Labia R; Beguin-Billecoq R; Guionie M
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():141-6. PubMed ID: 19810176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriological investigations with ceftazidime in vitro.
    Grimm H
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():213-6. PubMed ID: 19802986
    [No Abstract]   [Full Text] [Related]  

  • 6. Ceftazidime: summary of the first international symposium.
    Young LS
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():349-52. PubMed ID: 19803013
    [No Abstract]   [Full Text] [Related]  

  • 7. Why ceftazidime?
    Muggleton PW
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():1-3. PubMed ID: 19810166
    [No Abstract]   [Full Text] [Related]  

  • 8. The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.
    Vanhoof R; Gordts B; Coignau H; Stas G; Butzler JP
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():63-6. PubMed ID: 19802970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the in-vitro properties of ceftazidime with those of new broad-spectrum cephalosporins and gentamicin.
    Harris AM; Plested SJ; Harper PB
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():43-5. PubMed ID: 19810168
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of disk preparation on detection of metallo-beta-lactamase-producing isolates by the combined disk assay.
    Andrade SS; Picão RC; Campana EH; Nicoletti AG; Pignatari AC; Gales AC
    J Clin Microbiol; 2007 Jun; 45(6):2058-60. PubMed ID: 17409202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BSAC standardized disc susceptibility testing method (version 5).
    Andrews JM;
    J Antimicrob Chemother; 2006 Sep; 58(3):511-29. PubMed ID: 16840429
    [No Abstract]   [Full Text] [Related]  

  • 12. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
    Neu HC
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime: comparative in-vitro study.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test.
    Cafini F; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; González N; Coronel P; Prieto J
    Rev Esp Quimioter; 2010 Jun; 23(2):72-5. PubMed ID: 20559604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria.
    Chow AW; Bartlett KH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():91-5. PubMed ID: 19802974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin, ceftazidime, and moxifloxacin can be safely stored in single-use, polypropylene syringes.
    Armstrong BK; Mehta S; Kim SJ
    Retina; 2011 Nov; 31(10):2134-6. PubMed ID: 22027802
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae.
    Thabaut A; Durosoir JL; Saliou P
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():123-5. PubMed ID: 19810174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro properties of ceftazidime.
    Harper PB
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():5-13. PubMed ID: 19802965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uniformity in sensitivity test media.
    Waterworth PM
    J Antimicrob Chemother; 1978 Jan; 4(1):4-6. PubMed ID: 415034
    [No Abstract]   [Full Text] [Related]  

  • 20. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.